[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-661567-105":59,"doc-detail-661567-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","curriculum-vitae-fabio-nicolini","Curriculum Vitae Fabio Nicolini","","Curriculum Vitae of Fabio Nicolini, Ph.D., detailing personal information, education, and research experience in molecular biosciences, pharmaceutical biotechnology, and molecular oncology. The document outlines postdoctoral roles at IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) and Fondazione Umberto Veronesi, focused on CAR T cell therapies, therapeutic antibody identification, and immunotherapy research. It also lists key research projects, internships across major oncology research institutes in Spain, and academic training programs related to cancer stem cells and anticancer flavonoids, alongside awards, grants, and selected publications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/curriculum-vitae-fabio-nicolini/661567/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/curriculum-vitae-fabio-nicolini/661567.png","ImageObject",300,407,{"name":92,"@type":93},"Fishy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-10-28",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is Fabio Nicolini’s current research position?","Question",{"text":112,"@type":113},"He is a postdoctoral researcher of the Adoptive CAR T Cell Therapy platform at IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) in Meldola, Italy, since January 2020.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the main topics of his research experience?",{"text":117,"@type":113},"His work focuses on identifying and designing immunotherapies, including CAR-T and therapeutic antibodies, using patient B cell receptor repertoire analysis and supporting longitudinal monitoring projects for cancer management.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the document include besides research and education?",{"text":121,"@type":113},"It includes personal information, a list of awards and fellowships, and a selected set of publications with citations and DOIs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},661567,1793170567,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":143},14431098389841,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Curriculum Vitae Fabio Nicolini  \nFabio Nicolini, Ph.D.  \nIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \"Dino Amadori\"Via P. Maroncelli,40, 47014 Meldola (FC) Italy  \nemail: [fabio.nicolini@irst.emr.it](fabio.nicolini@irst.emr.it)  \nPEC: [fabio.nicolini@pecoberm.it](fabio.nicolini@pecoberm.it)  \n[Scopus Author Id:57214796312](Scopus Author Id:57214796312)  \n[ORCID ID:0000-0001-6846-5435](ORCID ID:0000-0001-6846-5435)  \n[RESEARCH ID:AAA-4517-2021](RESEARCH ID:AAA-4517-2021)  \nPersonal information  \n\n| Date of birth: 23 August 1985\u003Cbr>Place of birth: Rimini, Italy\u003Cbr>Citizenship: Italian\u003Cbr>Education |\n| --- |\n| 11/2012-06/2017 Ph. D. degree in Molecular Biosciences awarded by Autonoma University of Madrid, Spain.\u003Cbr>Experimental work carried out at the Centro de Investigaciones Biológicas – Consejo Superior de Investigación Científica (CIB-CSIC) in the Epigenetic control by the Polycomb Group of Genes laboratory headed by Dr. Miguel Angel Vidal, Madrid, Spain.\u003Cbr>10/2007-02/2010 Master's degree in Pharmaceutical Biotechnology ( 110/110) from the University of Bologna\u003Cbr>09/2004-10/2007 Bachelor's Degree in Biotechnology from the University of Bologna\u003Cbr>09/1999-10/2004 High school degree (Liceo Scientifico A. Einstein, Rimini)\u003Cbr>Research experience |\n\n01/2020 – today Postdoctoral researcher of the Adoptive CAR T Cell Therapy platform at Advanced Cellular Therapies and  \nRare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \"Dino Amadori\", Meldola, Italy.  \nIdentification and design of novel immunotherapies (i.e. CAR-T) and therapeutic antibodies to treat human malignancies (melanoma, breast cancer, mesothelioma,T-ALL)  \nIdentification of novel antibodies with therapeutic properties that can specifically target the cancer cells through analysis of the B cell receptor repertoire of patients  \nLongitudinal monItoring For the Earliest and BEst management for pLeural mesoThelioma (LIFEBELT)’’ -PNRR-TR1-2023-12378111  \nTheranostics fOr aGGressive Lung cancER TOGGLER: PNRR-POC-2023-12377322  \n09/2017 – 12/2019 Postdoctoral fellow of Fondazione Umberto Veronesi at IRCCS Istituto Romagnolo per lo Studio dei  \nTumori (IRST) \"Dino Amadori\" (SC oncologia clinica e sperimentale immunoterapia, tumori rari e centro risorse biologiche (CRB) .  \nIdentification of novel antibodies with therapeutic properties that can specifically target the cancer cells through analysis of the B lymphocyte repertoire of patients  \n11/2012-06/2017 Enrolled as PhD student of Autonoma University of Madrid in the Epigenetic control by the Polycomb  \nGroup of Genes laboratory headed by Dr. Miguel Angel Vidal at the Centro de Investigaciones Biológicas  \n– Consejo Superior de Investigación Científica (CIB-CSIC) , Madrid, Spain  \nRole of the Polycomb proteins in the epigenetic regulation of neuronal and hematopoietic stem cells: study concerning the Polycomb group proteins, regarding the neuronal stem cells’proliferation regulation  \n01/2011-01/2012 Postgraduate internship conducted at Centro Nacional de Investigación Oncológicas – Instituto de Salud  \nCarlos III (CNIO-ISCIII) Laboratory of molecular oncology directed by Dr. Mariano Barbacid, Madrid,Spain.  \nIdentification of cancer stem cells in the development of pancreatic adenocarcinoma  \n03/2009-10/2009 LLP Student/Erasmus Program: pursuing the Master's Thesis. Internship training at the Department of  \nPharmacology, University of Las Palmas de Gran Canaria.  \nCurriculum Vitae Fabio Nicolini  \nMaster's degree thesis title: Study and evaluation of the use of Flavonoids as anticancer agents.  \n04/2007-09/2007 Curricular internship for the Bachelor's Thesis at Institut de Biologia Molecular de Barcelona (I. B. M. B.-CSIC) , Department of Cell Biology, Institute of Molecular Biology, Barcelona, Spain. BC's degree thesis title: Study of the ubiquitin-protein ligase RNF8 and its possible interactions with the genome guardian protein p53  \nAwards, grants and honors  \n\n| 2018 | Post-doctor","cbCaidPp7EmV3e3B","https://ap.wps.com/l/cbCaidPp7EmV3e3B","pdf",324432,"English","# Personal information\n## Education\n## Research experience\n## Awards, grants and honors\n## Publications","[{\"question\":\"What is Fabio Nicolini’s current research position?\",\"answer\":\"He is a postdoctoral researcher of the Adoptive CAR T Cell Therapy platform at IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) in Meldola, Italy, since January 2020.\"},{\"question\":\"What are the main topics of his research experience?\",\"answer\":\"His work focuses on identifying and designing immunotherapies, including CAR-T and therapeutic antibodies, using patient B cell receptor repertoire analysis and supporting longitudinal monitoring projects for cancer management.\"},{\"question\":\"What does the document include besides research and education?\",\"answer\":\"It includes personal information, a list of awards and fellowships, and a selected set of publications with citations and DOIs.\"}]","Curriculum Vitae Fabio Nicolini | PDF",13]